Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
SKIN
Publication-derived

Skin Assembloids for Regenerative Medicine

Source Ebner-Peking et al. · Medical University of Graz, Graz, Austria · DOI

Duration: 21 days Cell source: Human iPSC / Primary
Regenerative medicine
No SOP yet
SKIN
Publication-derived

Skin Organoids for Developmental Studies

Source Shafiee et al. · Frazer Institute, University of Queensland / Herston Biofabrication Institute, Brisbane, Australia

Duration: 120 days Cell source: Human iPSC
Developmental biology
No SOP yet
SKIN
Publication-derived

Skin Organoids

Source Lee et al. · Boston Children's Hospital / Harvard Medical School, Boston, USA · DOI

Duration: 150 days Cell source: Human iPSC / Human ESC Full SOP · 5 phases · QC included
Characterisation
Full SOP with Academic or a plan
SKIN
Publication-derived

Skin Organoids for Regenerative Medicine

Source Lee et al. · Indiana University School of Medicine / Boston Children's Hospital, Boston, USA · DOI

Duration: 150 days Cell source: Human iPSC / Human ESC Full SOP · 7 phases · QC included
Regenerative medicine
Full SOP with Academic or a plan
VASCULAR
Publication-derived

Vascular Organoids for Disease Modelling

Source Adult Stem Cell Research Center, Seoul National University, Republic of Korea

Cell source: iPSC
Disease modelling
No SOP yet
VASCULAR
Publication-derived

Vascular Organoids for Toxicity Testing

Source IMBA — Institute of Molecular Biotechnology, Austrian Academy of Sciences, Vienna

Cell source: iPSC
Safety & toxicology
No SOP yet
THYROID
Publication-derived

Thyroid Models for Drug Screening

Source Weill Cornell Medicine (New York); Boston University Chobanian & Avedisian School of Medicine; Center for Regenerative Medicine, Boston, USA · DOI

Cell source: iPSC
Drug screening
No SOP yet
RETINA
Publication-derived

Retinal Models for Disease Modelling (2020)

Source Indiana University School of Medicine — Stark Neurosciences Research Institute, USA · DOI

Cell source: iPSC
Disease modelling
No SOP yet
RETINA
Publication-derived

Retinal Models for Regenerative Medicine (2025)

Source University of Iowa — Institute for Vision Research, Iowa City, USA · DOI

Cell source: iPSC
Regenerative medicine
No SOP yet
RETINA
Publication-derived

Retinal Models for Drug Screening (2024)

Source Indiana University School of Medicine — Stark Neurosciences Research Institute, Indianapolis, USA · DOI

Cell source: hPSC
Drug screening
No SOP yet
RETINA
Publication-derived

Retinal Organoids for Drug Screening

Source Institute of Molecular and Clinical Ophthalmology Basel (IOB) — Friedrich Miescher Institut; Novartis, Switzerland · DOI

Cell source: iPSC
Drug screening
No SOP yet
PROSTATE
Publication-derived

Prostate Organoids for Drug Screening

Source American University of Beirut (AUB) + Diverse klinische Partner — Internationale PCa-Organoid-Konsortien · DOI

Cell source: Patient-Derived
Drug screening
No SOP yet
PROSTATE
Publication-derived

Prostate Cancer Tumouroids

Source Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA · DOI

Duration: 56 days Cell source: Patient-Derived Full SOP · 6 phases · QC included
Full SOP with Academic or a plan
LUNG
Publication-derived

COVID-19 Lung Organoids

Source Garg/Bhatt Lab, University of California San Diego (UCSD), USA

Cell source: Adult Stem Cells
Disease modelling
No SOP yet
MUSCLE
Publication-derived

Duchenne Muscular Dystrophy Muscle Models

Source University College London (UCL) — Great Ormond Street Institute of Child Health, UK · DOI

Cell source: iPSC
Disease modelling
No SOP yet
MUSCLE
Publication-derived

Muscle Organoids for Disease and Development

Source Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany

Cell source: iPSC
Disease modelling
No SOP yet
MUSCLE
Publication-derived

Muscle Models for Regenerative Medicine

Source Okinawa Institute of Science and Technology (OIST); Ajou University School of Medicine, South Korea · DOI

Cell source: iPSC
Regenerative medicine
No SOP yet
MUSCLE
Publication-derived

Muscle Organoids for Disease Modelling

Source Max Planck Institute for Molecular Biomedicine, Münster; Ruhr University Bochum, Germany · DOI

Cell source: iPSC
Disease modelling
No SOP yet
MUSCLE
Publication-derived

Muscle Organoids for Drug Screening

Source University Medical Center Göttingen (UMG) — Institute of Pharmacology and Toxicology, Germany · DOI

Cell source: iPSC
Drug screening
No SOP yet
KIDNEY
Publication-derived

Kidney Models for Disease Modelling

Source Radboud University Medical Center (Radboudumc) — Dept. Nephrology, Nijmegen, Netherlands

Cell source: iPSC
Disease modelling
No SOP yet
KIDNEY
Publication-derived

Kidney Organoids for Drug Screening

Source Monash University — Institute for Molecular Bioscience, Brisbane, Australia

Cell source: iPSC
Drug screening
No SOP yet
BONE_CARTILAGE
Publication-derived

Bone and Cartilage Organoids for Drug Screening (2025)

Source Weill Cornell Medicine, New York, USA · DOI

Cell source: hESC
Drug screening
No SOP yet
BONE_CARTILAGE
Publication-derived

Bone and Cartilage Organoids for Disease Modelling

Source IMP / Vienna BioCenter / CeMM, Austria 🇦🇹 · DOI

Cell source: iPSC
Disease modelling
No SOP yet
BONE_CARTILAGE
Publication-derived

Bone and Cartilage Organoids for Drug Screening

Source MRC Weatherall Institute / NIHR Oxford Biomedical Research Centre, University of Oxford, UK

Cell source: iPSC
Drug screening
No SOP yet